Almac Doubles Analytical Capacity in US Headquarters
Almac
is pleased to announce the doubling of analytical capacity at its 240,000 sq. ft. North American Headquarters. The facility, built on a 40 acre site in Souderton, PA, north of Philadelphia, and occupied since 2010, delivers full-service, integrated clinical packaging, drug supply management, and technology solutions to pharmaceutical and biotech clients. The facility boasts state of the art analytical labs, supplementing existing facilities in the UK.
The analytical labs provide support for clinical packaging operations as well as stand-alone analytical services and are equipped with the latest equipment, including HPLC, UPLC, GC, UV, IR, DSC, KF and others. The additional lab investment will continue to offer these services as well as polymorph and salt screening and solid form development.
In continuing its investment, the new lab will also be equipped with the latest bathless dissolution apparatus for rapid and efficient comparative dissolution studies. This provides maximum flexibility for developing, validating and running assay, dissolution and stability methods, further complementing the large capacity stability chambers which provide all the required ICH stability conditions.
The analytical facility complements Almac’s specialty capabilities, including biocatalysis, radiolabelling, and peptide and protein synthesis. These services are all part of Almac’s comprehensive drug development services, including API and drug product development and GMP manufacture.
Almac will be exhibiting at the forthcoming Informex trade show, 14 – 17 February at Booth 2001.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
